and call business for everyone thanks and full for you, Thank our joining update the XXXX. quarter year fourth Ezgi,
very finish with to quarter first profitable strong all our progress business. and excited across a to solid are of elements our year report significant We a
our best patient has As Inspire commitment always, and experience that ensure patient possible first foremost outcomes the each to to with reiterate and we therapy.
the patient, demonstrate XXXX can population to access that including planned call, therapy, on benefit ongoing many improvements and accomplishments the technology our will Inspire. focus highlight During broaden from advancements and from we that today's to activities
We XXXX. and over there fiscal year will have Inspire therapy. completed milestones also now discuss our XX,XXX many outlook patients in received important for who XXXX, are We
of and silicone-based we and sensing Bluetooth MRI updates year, enabled digital received launched along body remote. made with Inspire full Inspire our with management compatibility, leads, platform system stimulation significant major FDA our the approval patient SleepSync Sleep patient including and Further, we app. to the progress During the a
care significantly Care pilot a scheduling access patient a to our initiated enhance believe also of through Program. digital Advisor will We which tool, we
important with gives of XXXX. achieved representing of the our In we the profitability quarter, which million, as population In first XX% to the $XXX.X in $XXX million for XXXX. let's review all fourth indication high enter us FDA, we the quarter, including addition, and we submitted in for noted expansions a for syndrome Down previously, patients We confidence Index. raised pediatric we results. time, revenue Hypopnea fourth With to compared as Apnea quarter the of generated increase and over cash, with the a fourth that,
For million, revenue compared the year year a full XXXX, $XXX.X increase of to totaled full XXXX. XX%
and to centers. utilization centers new higher existing growth the by activation supported Our by of driven continues at be
inventory to our levels. have silicone-based production challenges These the products experienced as we the During increasing the stimulation our due for supply and demand provide fourth resolved issues and sensing ability quarter, challenges we scaling to with our chain outpaced and the are with been leads bites.
high to the year. of plans reset the first were quarter the all we Despite start product seasonality of in deductible the in procedures providing these we scheduled have experienced challenges, successful fourth at Historically, due health for quarter. the in
supply chain the see may While quarter to fourth the first the quarter. slightly seasonality case, issues this XXXX in of the due remains less
compared we million In $XXX XX% year to the XX% that the quarter, end $XXX centers At centers, adding million XX XX new With a increase we continue quarter. the be planning said, and with up the total fourth XX of to to centers continue of U.S. revenue year to surgical of range XXX the XXXX. increase capacity ending by ambulatory in to in full of in to to centers, we expect our expect centers. fourth to XX% per XXXX, made of quarter, activate
territories we the XXX team, to quarter, sales territories. fourth Regarding our XX created the total bringing in U.S. sales new
XX optimize our will to our In increasing continue outcomes center training are per per to compared scale to ongoing and sales on sales XX teams XXXX quarter to We in quarter guidance in and our to patient expansion to and strong to productivity. XX focus territories XX XXXX. we add expect and management XXXX,
As such, our existing for at your utilization the centers. field on modified how to we incentive compensation organization focus
We will qualified interested continue to provider. to healthcare a our enhance ability patients connect with
through very primarily inspiresleep.com are website. generating in interest programs the Inspire in effective Our outreach therapy,
For office, include of an healthcare represent the full visitors these provider. million, over And these physician directly and Advisor calls the we our a emails patient's of from year-over-year. to website visits, XX Program XXXX, surpassed XX,XXX directly year number and to from had contacts. physician contacts of or to do XX% note, the a referrals our not Care physician's increase Of
in for From XXXX reimbursement November rules were in outlook providers. reimbursement providing final healthcare came and published a expected, as generally stable the for perspective, U.S. a
business year the continues prior our fourth exchange growing over year, strides, headwinds quarter make international despite XX% the to unfavorable the in prior ongoing from over on, Moving rates.
Germany, the market. global are international business U.S. in positives including our less was the in many quarter There quarter, during than the fourth the the strong significant performance the of During international highlighting X% and Switzerland. revenue, in growth Netherlands revenue
the registry the listed many preparations XXXX team the authorities, process French consistent the rest years the following to for the have of our the and there. world, reimbursement in launch rates early For with Inspire final continues more, of French we on in are at working with commercial
levels programs flagship productivity continue at consistent In perform centers. U.S. with Singapore, to our
see cases quarter. completed And should and additional we in in in in doing that our multiple Hong complete determination also first Kong, with reimbursement have momentum We [indiscernible] booked quarter Australia, we procedures February. have procedures submitted later for year. expect first a have read in or the fourth first Japan, centers the to also In this
Turning remote to on R&D, term, FDA our for our a with fifth Inspire programmer physician Health we SleepSync is Digital generation platform, which SleepSync for continue programming. neurostimulator. review. we to recently new step Longer of the submitted connects providing patient key design our programmer work next This generation
the to measure respiration. the an pressure accelerometer eliminate device neurostimulator using Inspire will and The X inside the incorporate sensing need sensor
we We qualification. and have the and conducting design production finalized operational are
into We XXXX. are late cycle, depending upon XXXX, still the targeting FDA and FDA review could approval move FDA this in early but
XXX continue first XXXX. step initial to apnea continue finished fourth study, we the BMI in first office clinical enrolling drug and patients to with of data for the In replacing quarter, of to sleep who which clap in the can Finally, therapy. to our with less increase measurement the of for number a for induced research procedure Inspire PREDICTOR we trials is the based benefit than readout the requirement an conduct patients patients from XX and
increase XXXX experiencing focused continue existing to patient business. we're adoption beyond, utilization significant We physician to on at education and summary, outcomes therapy. and momentum remain the we all financial of In of opening will aspects our our In continue new improved in these our and our are investment these The our capacity call we're which driving and adding and centers, while DTC from seeing training support center ongoing enhanced by efforts, performance. in centers. expansion campaign of initiatives, our productivity
excited commitment to the and our Finally, confident prospects the many value. our and extremely R&D providers we health improving Inspire strategy the highlight We to future are enhancing therapy. that patient achievements both experience remain and stakeholder long-term outcomes to in in drive XXXX within place have appropriate care about patients
over call like our that, to review for his of With financials. I'd to Rick turn the